Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

TPAV, LLC — Traws Pharma, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / TPAV, LLC

TPAV, LLC

10% owner at Traws Pharma, Inc. · on record since Apr 11, 2024

Insider trading activity of TPAV, LLC

Transactions on record: 2; since Jan 27, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 27, 2025

Figures computed from official regulatory filings — methodology.

Companies where TPAV, LLC has traded

Traws Pharma, Inc.2 tx · Jan 27, 2025

Track record of TPAV, LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of TPAV, LLC

Co-insiders of TPAV, LLC

683 Capital Management, LLCTraws Pharma, Inc.
683 Capital Partners, LPTraws Pharma, Inc.
Altland JamesTraws Pharma, Inc.
ARMISTICE CAPITAL, LLCTraws Pharma, Inc.
Armistice Capital Master Fund Ltd.Traws Pharma, Inc.
Atadja PeterTraws Pharma, Inc.
BANSAL AJAYTraws Pharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Baxalta GmbHTraws Pharma, Inc.

Baxalta IncTraws Pharma, Inc.

Baxter Healthcare SATraws Pharma, Inc.

BAXTER INTERNATIONAL INCTraws Pharma, Inc.

Bienen Henry STraws Pharma, Inc.

Boyd StevenTraws Pharma, Inc.

Brennan NoraTraws Pharma, Inc.

CAUTREELS WERNERTraws Pharma, Inc.

Clarke TraffordTraws Pharma, Inc.

Dukes Iain D.Traws Pharma, Inc.

Fruchtman Steven MTraws Pharma, Inc.

Gelder Mark S. MDTraws Pharma, Inc.

Greenwood LubaTraws Pharma, Inc.

GROOPMAN JEROMETraws Pharma, Inc.

Guerin Mark PatrickTraws Pharma, Inc.

Hoffman Michael BTraws Pharma, Inc.

Kumar RameshTraws Pharma, Inc.

Leaman John HaroldTraws Pharma, Inc.

Maniar ManojTraws Pharma, Inc.

MARINO JAMES JTraws Pharma, Inc.

MCKEARN THOMAS JTraws Pharma, Inc.

MEHTA VIRENTraws Pharma, Inc.

Michael & Jane Hoffman 2013 DescendantsTraws Pharma, Inc.

Moyo Victor MTraws Pharma, Inc.

OLER ABRAHAM N.Traws Pharma, Inc.

ORBIMED ADVISORS LLCTraws Pharma, Inc.

OrbiMed Capital GP VIII LLCTraws Pharma, Inc.

Parker Charles NolanTraws Pharma, Inc.

Pauza Charles DavidTraws Pharma, Inc.

Reddy E PremkumarTraws Pharma, Inc.

Redfield RobertTraws Pharma, Inc.

Savchuk NikolayTraws Pharma, Inc.

Shoemaker Mary TeresaTraws Pharma, Inc.

STOVER JACK ETraws Pharma, Inc.

TYNDALL CAPITAL PARTNERS L PTraws Pharma, Inc.

VANLENT ANNETraws Pharma, Inc.

Viriom, Inc.Traws Pharma, Inc.

Woodman Richard CharlesTraws Pharma, Inc.

Zweiman AriTraws Pharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Traws Pharma, Inc.	Jan 27, 2025	BuyD	96,348	—	—	SEC
Traws Pharma, Inc.	Jan 27, 2025	BuyD	96,348	—	—	SEC